Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeEXECUTIVESWarren Modlin Joins HOYA Vision Care As VP of Marketing

Warren Modlin Joins HOYA Vision Care As VP of Marketing

Warren Modlin has joined the company as its Vice President of Technical Marketing. In his role, Modlin leads professional relations and innovation strategies for North America, in addition to representing the North American market and delivering on key global initiatives alongside Research & Development.


Trained as an optometrist in South Africa and based in California, Warren Modlin brings more than 30 years of optical industry experience to HOYA, beginning with his 12-year tenure at CIBA VISION where he contributed to the launch of many innovative lens technologies. He also held leadership positions at Oakley and has launched optical businesses including two consultancies and NDV Performance.

“I am excited to join a company that is equally dedicated to supporting its customers with innovative products and unparalleled service,” said Warren Modlin. “Product innovation and technical quality is the life blood of a great company. I feel strongly that HOYA is best positioned to take advantage of the next generation of technology innovations to help ECPs and consumers achieve their maximum potential through vision performance.”

“We are very happy to welcome Warren to our global team of visionaries,” said Eduardo Martins, President of HOYA Vision CareNorth America. “Our customers will no doubt benefit from the deep industry knowledge and marketing experience he brings to our company.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy